BioSpace News Archive

Biotech Beach

Rigel Announces Availability of TAVALISSE™ (fostamatinib disodium hexahydrate) in the U.S.

Rigel Pharmaceuticals, Inc. announced that TAVALISSE™ (fostamatinib disodium hexahydrate) is available by prescription for the treatment of thrombocytopenia in adult patients.

May 29, 2018

·

7 min read

BioMidwest

Health Catalyst One of Inc. Magazine’s Best Workplaces 2018

Health Catalys has been named one of Inc. magazine’s Best Workplaces for 2018.

May 29, 2018

·

2 min read

FDA

U.S. FDA Grants Priority Review to Astellas’ New Drug Application for Gilteritinib for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)

FLT3 mutations impact approximately 30 percent of AML patients and are often associated with poor survival outcomes.

May 29, 2018

·

6 min read

Policy

Volumes Achieved as Haiti’s ‘Change Caravan’ Marks Its First Year

In the one year since Haiti’s President Jovenel Moïse launched his flagship ‘Change Caravan’ initiative, the country has experienced significant improvements across several areas.

May 29, 2018

·

3 min read

Biotech Bay

Invokana: The Diabetic Drug That Costs a Limb

29 million people have type 2 diabetes in the U.S. making it big business for pharmaceutical companies.

May 29, 2018

·

2 min read

Biotech Beach

Kush Bottles CEO Nick Kovacevich to Speak at Cannabis World Congress & Business Exposition in New York City

Kush Bottles, Inc. announced that CEO Nick Kovacevich will be participating on several panels at the Cannabis World Congress & Business Exposition (CWCBExpo) being held this week at the Javits Center in New York City.

May 29, 2018

·

5 min read

Isolation and Recombinant Expression of Key Enzyme for Opioid Production

Intrexon Corporation announced the isolation and recombinant expression of a novel gene from the opium poppy (Papaver somniferum) encoding the enzyme, thebaine synthase.

May 29, 2018

·

5 min read

Pharm Country

Cannabis and CBD Markets are Set to Increase in Value

According to a report by Hexa Research, the U.S. medical cannabis market is projected to reach $19.48 billion by 2024.

May 29, 2018

·

10 min read

Biotech Beach

Medical Marijuana, Inc. CEO to Speak on Medical Cannabis Research at 5th Annual Cannabis World Congress and Business Expo in New York

Medical Marijuana, Inc. announced that at the 5th Annual Cannabis World Congress and Business Expo (CWCBE), taking place in New York City from May 31-June 2, the company’s Chief Executive Officer Dr. Stuart Titus will speak on medical cannabis and cannabidiol (CBD) research on May 31.

May 29, 2018

·

4 min read

Genetown

EMD Serono to Present MS Data and Debut New Patient Resources at CMSC 2018

EMD Serono announced that six abstracts including two poster presentations on Cladribine Tablets.

May 29, 2018

·

7 min read